MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS)
Clinical trials for MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS) explained in plain language.
Never miss a new study
Get alerted when new MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS) trials appear
Sign up with your email to follow new studies for MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New ultrasound device could replace costly MRI for liver fat checks
Diagnosis Recruiting nowThis study tests a new device that uses sound waves to measure fat in the liver. About 49 adults will get a scan with this device and then an MRI to compare results. The goal is to create a simpler, more affordable way to check liver fat, which is linked to overall health and dis…
Matched conditions: MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS)
Sponsor: Endra Lifesciences • Aim: Diagnosis
Last updated May 14, 2026 12:02 UTC
-
Gene hunt: could your DNA predict fatty liver risk?
Knowledge-focused Recruiting nowThis study looks at how certain gene variations (PNPLA3) are linked to fatty liver disease (MASLD) in people from Guadeloupe, French Guiana, and Réunion Island. Researchers will collect blood samples from 600 adults to find out which gene versions are most common and how they rel…
Matched conditions: MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS)
Sponsor: Centre Hospitalier Universitaire de la Guadeloupe • Aim: Knowledge-focused
Last updated May 17, 2026 05:34 UTC
-
Cancer survivors face hidden liver risk – new study aims to catch it early
Knowledge-focused Recruiting nowThis study looks at why breast and colorectal cancer survivors may be at higher risk for a common liver condition called MASLD (fatty liver disease). Researchers will use painless scans and blood tests to check for liver damage in 200 survivors. The goal is to find better ways to…
Matched conditions: MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS)
Sponsor: University of Bern • Aim: Knowledge-focused
Last updated May 05, 2026 11:53 UTC